Selection of original papers

Reuschenbach M, Waterboer T, Wallin KL, Einenkel J, Dillner J, Hamsikova E,
Eschenbach D, Zimmer H, Heilig B, Kopitz J, Pawlita M, Doeberitz MK, Wentzensen
N.
Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16
E7 in patients with HPV-associated cancers.
Int J Cancer. 2008 Dec 1;123(11):2626-31.

Rollison DE, Pawlita M, Giuliano AR, Iannacone MR, Sondak VK, Messina JL,
Cruse CW, Fenske NA, Glass LF, Kienstra M, Michael KM, Waterboer T, Gheit T,
Tommasino M.
Measures of cutaneous human papillomavirus infection in normal tissues as
biomarkers of HPV in corresponding nonmelanoma skin cancers.
Int J Cancer. 2008 Nov 15;123(10):2337-42.

Dell'oste V, Azzimonti B, De Andrea M, Mondini M, Zavattaro E, Leigheb G,
Weissenborn SJ, Pfister H, Michael KM, Waterboer T, Pawlita M, Amantea A,
Landolfo S, Gariglio M.
High beta-HPV DNA Loads and Strong Seroreactivity Are Present in
Epidermodysplasia Verruciformis.
J Invest Dermatol. 2008 Oct 16. [Epub ahead of print]

Förster G, Boltze C, Seidel J, Pawlita M, Müller A.
[Juvenile Laryngeal Papillomatosis - Immunisation with the Polyvalent Vaccine
Gardasil(R).]
Laryngorhinootologie. 2008 Aug 29. [Epub ahead of print] German.

Waterboer T, Abeni D, Sampogna F, Rother A, Masini C, Sehr P, Michael KM,
Pawlita M.
Serological association of beta and gamma human papillomaviruses with squamous
cell carcinoma of the skin.
Br J Dermatol. 2008 Aug;159(2):457-9. Epub 2008 May 22.

Dondog B, Clifford GM, Vaccarella S, Waterboer T, Unurjargal D, Avirmed D,
Enkhtuya S, Kommoss F, Wentzensen N, Snijders PJ, Meijer CJ, Franceschi S,
Pawlita M.
Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based
study.
Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1731-8.

Michael KM, Waterboer T, Sehr P, Rother A, Reidel U, Boeing H, Bravo IG,
Schlehofer J, Gärtner BC, Pawlita M.
Seroprevalence of 34 human papillomavirus types in the German general population.
PLoS Pathog. 2008 Jun 20;4(6):e1000091.

Patel AS, Karagas MR, Pawlita M, Waterboer T, Nelson HH.
Cutaneous human papillomavirus infection, the EVER2 gene and incidence of
squamous cell carcinoma: a case-control study.
Int J Cancer. 2008 May 15;122(10):2377-9.

Sabol I, Salakova M, Smahelova J, Pawlita M, Schmitt M, Gasperov NM, Grce M,
Tachezy R.
Evaluation of different techniques for identification of human papillomavirus
types of low prevalence.
J Clin Microbiol. 2008 May;46(5):1606-13. Epub 2008 Mar 5.

Schmitt M, Dondog B, Waterboer T, Pawlita M.
Homogeneous amplification of genital human alpha papillomaviruses by PCR using
novel broad-spectrum GP5+ and GP6+ primers.
J Clin Microbiol. 2008 Mar;46(3):1050-9. Epub 2008 Jan 16.

Andersson K, Waterboer T, Kirnbauer R, Slupetzky K, Iftner T, de Villiers EM,
Forslund O, Pawlita M, Dillner J.
Seroreactivity to cutaneous human papillomaviruses among patients with
nonmelanoma skin cancer or benign skin lesions.
Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):189-95.

Rizk RZ, Christensen ND, Michael KM, Müller M, Sehr P, Waterboer T, Pawlita
M.
Reactivity pattern of 92 monoclonal antibodies with 15 human papillomavirus
types.
J Gen Virol. 2008 Jan;89(Pt 1):117-29.

Kaufmann AM, Nieland JD, Jochmus I, Baur S, Friese K, Gabelsberger J,
Gieseking F, Gissmann L, Glasschröder B, Grubert T, Hillemanns P, Höpfl R,
Ikenberg H, Schwarz J, Karrasch M, Knoll A, Küppers V, Lechmann M, Lelle RJ,
Meissner H, Müller RT, Pawlita M, Petry KU, Pilch H, Walek E, Schneider A.
Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women
suffering from high grade cervical intraepithelial neoplasia (CIN 2/3).
Int J Cancer. 2007 Dec 15;121(12):2794-800.

Smeets SJ, Hesselink AT, Speel EJ, Haesevoets A, Snijders PJ, Pawlita M,
Meijer CJ, Braakhuis BJ, Leemans CR, Brakenhoff RH.
A novel algorithm for reliable detection of human papillomavirus in paraffin
embedded head and neck cancer specimen.
Int J Cancer. 2007 Dec 1;121(11):2465-72.

Casabonne D, Michael KM, Waterboer T, Pawlita M, Forslund O, Burk RD, Travis
RC, Key TJ, Newton R.
A prospective pilot study of antibodies against human papillomaviruses and
cutaneous squamous cell carcinoma nested in the Oxford component of the European
Prospective Investigation into Cancer and Nutrition.
Int J Cancer. 2007 Oct 15;121(8):1862-8.

Heideman DA, Waterboer T, Pawlita M, Delis-van Diemen P, Nindl I, Leijte JA,
Bonfrer JM, Horenblas S, Meijer CJ, Snijders PJ.
Human papillomavirus-16 is the predominant type etiologically involved in penile
squamous cell carcinoma.
J Clin Oncol. 2007 Oct 10;25(29):4550-6.

Clifford GM, Shin HR, Oh JK, Waterboer T, Ju YH, Vaccarella S, Quint W,
Pawlita M, Franceschi S.
Serologic response to oncogenic human papillomavirus types in male and female
university students in Busan, South Korea.
Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1874-9.

Romen F, Backes P, Materniak M, Sting R, Vahlenkamp TW, Riebe R, Pawlita M,
Kuzmak J, Löchelt M.
Serological detection systems for identification of cows shedding bovine foamy
virus via milk.
Virology. 2007 Jul 20;364(1):123-31. Epub 2007 Apr 3.

Kjaerheim K, Røe OD, Waterboer T, Sehr P, Rizk R, Dai HY, Sandeck H, Larsson
E, Andersen A, Boffetta P, Pawlita M.
Absence of SV40 antibodies or DNA fragments in prediagnostic mesothelioma serum
samples.
Int J Cancer. 2007 Jun 1;120(11):2459-65.

Sehr P, Pawlita M, Lewis J.
Evaluation of different glutathione S-transferase-tagged protein captures for
screening E6/E6AP interaction inhibitors using AlphaScreen.
J Biomol Screen. 2007 Jun;12(4):560-7. Epub 2007 May 3.

D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH,
Gillison ML.
Case-control study of human papillomavirus and oropharyngeal cancer.
N Engl J Med. 2007 May 10;356(19):1944-56.

Smith EM, Ritchie JM, Pawlita M, Rubenstein LM, Haugen TH, Turek LP,
Hamsikova E.
Human papillomavirus seropositivity and risks of head and neck cancer.
Int J Cancer. 2007 Feb 15;120(4):825-32.

Pagliusi SR, Dillner J, Pawlita M, Quint WG, Wheeler CM, Ferguson M.
Chapter 23: International Standard reagents for harmonization of HPV serology and
DNA assays--an update.
Vaccine. 2006 Aug 31;24 Suppl 3:S3/193-200. Epub 2006 Jun 23. Review.

Dang C, Koehler A, Forschner T, Sehr P, Michael K, Pawlita M, Stockfleth E,
Nindl I.
E6/E7 expression of human papillomavirus types in cutaneous squamous cell
dysplasia and carcinoma in immunosuppressed organ transplant recipients.
Br J Dermatol. 2006 Jul;155(1):129-36.

Visser J, van Baarle D, Hoogeboom BN, Reesink N, Klip H, Schuuring E, Nijhuis
E, Pawlita M, Bungener L, de Vries-Idema J, Nijman H, Miedema F, Daemen T, van
der Zee A.
Enhancement of human papilloma virus type 16 E7 specific T cell responses by
local invasive procedures in patients with (pre)malignant cervical neoplasia.
Int J Cancer. 2006 May 15;118(10):2529-37.

Karagas MR, Nelson HH, Sehr P, Waterboer T, Stukel TA, Andrew A, Green AC,
Bavinck JN, Perry A, Spencer S, Rees JR, Mott LA, Pawlita M.
Human papillomavirus infection and incidence of squamous cell and basal cell
carcinomas of the skin.
J Natl Cancer Inst. 2006 Mar 15;98(6):389-95.

Waterboer T, Sehr P, Pawlita M.
Suppression of non-specific binding in serological Luminex assays.
J Immunol Methods. 2006 Feb 20;309(1-2):200-4. Epub 2005 Dec 19.

Romen F, Pawlita M, Sehr P, Bachmann S, Schröder J, Lutz H, Löchelt M.
Antibodies against Gag are diagnostic markers for feline foamy virus infections
while Env and Bet reactivity is undetectable in a substantial fraction of
infected cats.
Virology. 2006 Feb 20;345(2):502-8. Epub 2005 Nov 16.

Schmitt M, Bravo IG, Snijders PJ, Gissmann L, Pawlita M, Waterboer T.
Bead-based multiplex genotyping of human papillomaviruses.
J Clin Microbiol. 2006 Feb;44(2):504-12.

Bleker S, Pawlita M, Kleinschmidt JA.
Impact of capsid conformation and Rep-capsid interactions on adeno-associated
virus type 2 genome packaging.
J Virol. 2006 Jan;80(2):810-20.

Waterboer T, Sehr P, Michael KM, Franceschi S, Nieland JD, Joos TO, Templin
MF, Pawlita M.
Multiplex human papillomavirus serology based on in situ-purified glutathione
s-transferase fusion proteins.
Clin Chem. 2005 Oct;51(10):1845-53. Epub 2005 Aug 11.

Findeisen P, Kloor M, Merx S, Sutter C, Woerner SM, Dostmann N, Benner A,
Dondog B, Pawlita M, Dippold W, Wagner R, Gebert J, von Knebel Doeberitz M.
T25 repeat in the 3' untranslated region of the CASP2 gene: a sensitive and
specific marker for microsatellite instability in colorectal cancer.
Cancer Res. 2005 Sep 15;65(18):8072-8.

Renner ED, Pawlita I, Hoffmann F, Hornung V, Hartl D, Albert M, Jansson A,
Endres S, Hartmann G, Belohradsky BH, Rothenfusser S.
No indication for a defect in toll-like receptor signaling in patients with
hyper-IgE syndrome.
J Clin Immunol. 2005 Jul;25(4):321-8.

Kreimer AR, Clifford GM, Snijders PJ, Castellsagué X, Meijer CJ, Pawlita M,
Viscidi R, Herrero R, Franceschi S; International Agency for Research on Cancer
(IARC) Multicenter Oral Cancer Study Group.
HPV16 semiquantitative viral load and serologic biomarkers in oral and
oropharyngeal squamous cell carcinomas.
Int J Cancer. 2005 Jun 10;115(2):329-32.

Chen R, Sehr P, Waterboer T, Leivo I, Pawlita M, Vaheri A, Aaltonen LM.
Presence of DNA of human papillomavirus 16 but no other types in tumor-free
tonsillar tissue.
J Clin Microbiol. 2005 Mar;43(3):1408-10.

Langner J, Neumann B, Goodman SL, Pawlita M.
RGD-mutants of B-lymphotropic polyomavirus capsids specifically bind to
alpha(v)beta3 integrin.
Arch Virol. 2004 Oct;149(10):1877-96.

Barth TF, Müller S, Pawlita M, Siebert R, Rother JU, Mechtersheimer G,
Kitinya J, Bentz M, Möller P.
Homogeneous immunophenotype and paucity of secondary genomic aberrations are
distinctive features of endemic but not of sporadic Burkitt's lymphoma and
diffuse large B-cell lymphoma with MYC rearrangement.
J Pathol. 2004 Aug;203(4):940-5.

Davidson EJ, Faulkner RL, Sehr P, Pawlita M, Smyth LJ, Burt DJ, Tomlinson AE,
Hickling J, Kitchener HC, Stern PL.
Effect of TA-CIN (HPV 16 L2E6E7) booster immunisation in vulval intraepithelial
neoplasia patients previously vaccinated with TA-HPV (vaccinia virus encoding HPV
16/18 E6E7).
Vaccine. 2004 Jul 29;22(21-22):2722-9.

Smyth LJ, Van Poelgeest MI, Davidson EJ, Kwappenberg KM, Burt D, Sehr P,
Pawlita M, Man S, Hickling JK, Fiander AN, Tristram A, Kitchener HC, Offringa R,
Stern PL, Van Der Burg SH.
Immunological responses in women with human papillomavirus type 16
(HPV-16)-associated anogenital intraepithelial neoplasia induced by heterologous
prime-boost HPV-16 oncogene vaccination.
Clin Cancer Res. 2004 May 1;10(9):2954-61.

von Einsiedel RW, Samorei IW, Pawlita M, Zwissler B, Deubel M, Vinters HV.
New JC virus infection patterns by in situ polymerase chain reaction in brains of
acquired immunodeficiency syndrome patients with progressive multifocal
leukoencephalopathy.
J Neurovirol. 2004 Feb;10(1):1-11.

Dai M, Clifford GM, le Calvez F, Castellsagué X, Snijders PJ, Pawlita M,
Herrero R, Hainaut P, Franceschi S; IARC Multicenter Oral Cancer Study Group.
Human papillomavirus type 16 and TP53 mutation in oral cancer: matched analysis
of the IARC multicenter study.
Cancer Res. 2004 Jan 15;64(2):468-71.

Herrero R, Castellsagué X, Pawlita M, Lissowska J, Kee F, Balaram P, Rajkumar
T, Sridhar H, Rose B, Pintos J, Fernández L, Idris A, Sánchez MJ, Nieto A,
Talamini R, Tavani A, Bosch FX, Reidel U, Snijders PJ, Meijer CJ, Viscidi R,
Muñoz N, Franceschi S; IARC Multicenter Oral Cancer Study Group.
Human papillomavirus and oral cancer: the International Agency for Research on
Cancer multicenter study.
J Natl Cancer Inst. 2003 Dec 3;95(23):1772-83.

Davidson EJ, Boswell CM, Sehr P, Pawlita M, Tomlinson AE, McVey RJ, Dobson J,
Roberts JS, Hickling J, Kitchener HC, Stern PL.
Immunological and clinical responses in women with vulval intraepithelial
neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18
oncoproteins.
Cancer Res. 2003 Sep 15;63(18):6032-41.

Oetke C, Hinderlich S, Reutter W, Pawlita M.
Epigenetically mediated loss of UDP-GlcNAc 2-epimerase/ManNAc kinase expression
in hyposialylated cell lines.
Biochem Biophys Res Commun. 2003 Sep 5;308(4):892-8.

Nonn M, Schinz M, Zumbach K, Pawlita M, Schneider A, Dürst M, Kaufmann AM.
Dendritic cell-based tumor vaccine for cervical cancer I: in vitro stimulation
with recombinant protein-pulsed dendritic cells induces specific T cells to HPV16
E7 or HPV18 E7.
J Cancer Res Clin Oncol. 2003 Sep;129(9):511-20. Epub 2003 Aug 2.

Ferrara A, Nonn M, Sehr P, Schreckenberger C, Pawlita M, Dürst M, Schneider
A, Kaufmann AM.
Dendritic cell-based tumor vaccine for cervical cancer II: results of a clinical
pilot study in 15 individual patients.
J Cancer Res Clin Oncol. 2003 Sep;129(9):521-30. Epub 2003 Jul 30.

Davidson EJ, Sehr P, Faulkner RL, Parish JL, Gaston K, Moore RA, Pawlita M,
Kitchener HC, Stern PL.
Human papillomavirus type 16 E2- and L1-specific serological and T-cell responses
in women with vulval intraepithelial neoplasia.
J Gen Virol. 2003 Aug;84(Pt 8):2089-97.

Willhauck M, Scheibenbogen C, Pawlita M, Möhler T, Thiel E, Keilholz U.
Restricted T-cell receptor repertoire in melanoma metastases regressing after
cytokine therapy.
Cancer Res. 2003 Jul 1;63(13):3483-5.

Ohlschläger P, Osen W, Dell K, Faath S, Garcea RL, Jochmus I, Müller M,
Pawlita M, Schäfer K, Sehr P, Staib C, Sutter G, Gissmann L.
Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T
lymphocytes and tumor regression in C57BL/6 mice.
J Virol. 2003 Apr;77(8):4635-45.

to top